Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Kafrelsheikh University

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Employees: -

Market Cap: -

Website: http://kfs.edu.eg

Clinical Trials

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Phase 2

Conditions: COVID-19

Interventions: Other: Placebo
Drug: Aerosolized 13 cis retinoic acid
Drug: Aerosolized All trans retinoic acid

First Posted Date: 2020-05-20

Last Posted Date: 2020-10-27

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 360

Registration Number: NCT04396067

Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

Phase 2

Conditions: COVID-19

Interventions: Drug: Aerosolized Isotretinoin plus Tamoxifen

First Posted Date: 2020-05-15

Last Posted Date: 2021-07-16

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 160

Registration Number: NCT04389580

Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications

Phase 1

Conditions: COVID

Interventions: Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid

First Posted Date: 2020-05-11

Last Posted Date: 2021-06-09

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 24

Registration Number: NCT04382950

Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising Treatment for COVID-19 Infection- and Its Inflammatory Complications Better Than Recombinant Human ACE2

Phase 1

Conditions: COVID-19

Interventions: Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2)

First Posted Date: 2020-05-05

Last Posted Date: 2021-06-09

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 24

Registration Number: NCT04375046

Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients

Phase 1

Conditions: COVID-19

Interventions: Drug: SnPP Protoporphyrin plus Sunlight exposure
Other: placebo
Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.

First Posted Date: 2020-05-01

Last Posted Date: 2020-06-24

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 56

Registration Number: NCT04371822

Locations: 🇪🇬
Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt

Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.

Not Applicable

Conditions: Renal Stones
Nephrolithiasis

Interventions: Drug: Tranexamic acid injection

First Posted Date: 2020-04-29

Last Posted Date: 2021-03-03

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 200

Registration Number: NCT04367155

Locations: 🇪🇬
Kafrelsheikh faculty of medicine, Kafr Ash Shaykh, Kafrelsheikh, Egypt

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)

Phase 3

Conditions: COVID19

Interventions: Drug: Isotretinoin (13 cis retinoic acid ) capsules
Drug: Aerosolized 13 cis retinoic acid
Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment
Drug: Standard treatment

First Posted Date: 2020-04-20

Last Posted Date: 2021-08-05

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 100000

Registration Number: NCT04353180

Locations: 🇪🇬
Faculty of Medicine, Kafr El-sheikh University, Cairo, Egypt

Bladder and Prostate Sonomorphology in Patients With Symptomatic Benign Prostatic Hyperplasia

Conditions: Benign Prostatic Hyperplasia

Interventions: Radiation: pelvic Ultrasound

First Posted Date: 2020-04-20

Last Posted Date: 2020-04-20

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 200

Registration Number: NCT04352257

Locations: 🇪🇬
Kafrelsheikh faculty of medicine, Kafr Ash Shaykh, Kafrelsheikh, Egypt

Prone Flexed Position in Percutanous Nephrolithotomy

Not Applicable

Completed

Conditions: Renal Stones

Interventions: Procedure: Percutanous nephrolithotomy (PCNL)

First Posted Date: 2020-04-14

Last Posted Date: 2020-04-15

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 300

Registration Number: NCT04345835

Locations: 🇪🇬
Kafrelsheikh faculty of medicine, Kafr Ash Shaykh, Kafrelsheikh, Egypt

N-Acetyl-Cysteine for Treatment of AGA in Men

Phase 4

Conditions: Androgenetic Alopecia

Interventions: Drug: Minoxidil 5% topically and oral NAC 600 mg

First Posted Date: 2019-12-24

Last Posted Date: 2020-02-20

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 100

Registration Number: NCT04209803

Locations: 🇪🇬
dermatology clinics in Ain Shams University Hospital and Kafr El Sheik University Hospital., Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy